Lemaitre Vascular (LMAT) Deferred Taxes (2010 - 2013)
Lemaitre Vascular (LMAT) posted quarterly Deferred Taxes of $274000.0 for Q4 2013, up 6750.0% quarter-over-quarter from $4000.0 in Q1 2012.
Lemaitre Vascular (LMAT) Deferred Taxes (2010 - 2013) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Deferred Taxes for 3 consecutive years, with $274000.0 the latest figure, recorded in Q4 2013.
- In Q4 2013, Deferred Taxes changed N/A year-over-year to $274000.0; the TTM figure through Dec 2013 stood at -$2.2 million (changed N/A YoY), while the FY2025 annual figure was $2.3 million, up 612.64% from the prior year.
- Deferred Taxes advanced to $274000.0 in Q4 2013 per LMAT's latest filing, from $4000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $274000.0 in Q4 2013 and bottomed at -$2.6 million in Q4 2010.
- Historically, Deferred Taxes has averaged -$560500.0 across 3 years, with a median of $49000.0 in 2010.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -31.00 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -74.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 64.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -47.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 43.50 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -34.00 Mn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 274,000.00 |
| Mar 31, 2012 | 4,000.00 |
| Dec 31, 2010 | -2.61 Mn |
| Sep 30, 2010 | 94,000.00 |